NP428115.RAiqTN-vqCo9xCOPR6-hzPJhG N6j2OYfj-2hym349-gA
type: Nanopublication
has assertion: NP428115.RAiqTN-vqCo9xCOPR6-hzPJhG N6j2OYfj-2hym349-gA130 assertion
has provenance: NP428115.RAiqTN-vqCo9xCOPR6-hzPJhG N6j2OYfj-2hym349-gA130 provenance
has publication info: NP428115.RAiqTN-vqCo9xCOPR6-hzPJhG N6j2OYfj-2hym349-gA130 publicationInfo
created: 2014-10-02T12:36:14+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetrdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v2.1.0.0

NP428115.RAiqTN-vqCo9xCOPR6-hzPJhG N6j2OYfj-2hym349-gA130 assertion
type: Assertion
description: [However, while the inhibition of DNA topoisomerase 1 activity by FL118 was no better than the active form of irinotecan, SN-38 at 1 µM, FL118 effectively inhibited cancer cell growth at less than nM levels in a p53 status-independent manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/23029106
was generated by: ECO_0000203

befree-20140225
imported on: 2014-02-25

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetrdf
version: v2.1.0